SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-18-001005
Filing Date
2018-10-15
Accepted
2018-10-15 18:18:39
Documents
1
Period of Report
2018-10-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3077
  Complete submission text file 0001123292-18-001005.txt   4687
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INNOVATION PHARMACEUTICALS INC. 100 CUMMINGS CENTER, SUITE 151-B BEVERLY MA 01915
Business Address
Bertolino Arthur Peter (Reporting) CIK: 0001426344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37357 | Film No.: 181123259